Genesis IBRC India [GENESIS] vs Zota Health Care [ZOTA] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Genesis IBRC India Ltd. wins in 10 metrics, Zota Health Care Limited wins in 4 metrics, with 1 ties. Genesis IBRC India Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Genesis IBRC India Ltd. Zota Health Care Limited Better
P/E Ratio (TTM) 57.89 -62.53 Genesis IBRC India Ltd.
Price-to-Book Ratio 9.93 12.61 Genesis IBRC India Ltd.
Debt-to-Equity Ratio 0.00 56.90 Tie
PEG Ratio N/A -0.59 N/A
EV/EBITDA 26.95 -126.59 Genesis IBRC India Ltd.
Profit Margin (TTM) 2.36% -15.37% Genesis IBRC India Ltd.
Operating Margin (TTM) -11.05% -15.88% Genesis IBRC India Ltd.
Return on Equity 0.08% -24.83% Genesis IBRC India Ltd.
Return on Assets (TTM) 0.05% -12.84% Genesis IBRC India Ltd.
Free Cash Flow (TTM) $-3,000 $-959.42M Genesis IBRC India Ltd.
Dividend Yield N/A 0.07% N/A
1-Year Return 507.27% 12.58% Genesis IBRC India Ltd.
Price-to-Sales Ratio (TTM) 1,399.83 8.34 Zota Health Care Limited
Enterprise Value $944.70M $45.66B Zota Health Care Limited
EV/Revenue Ratio 326.10 9.66 Zota Health Care Limited
Gross Profit Margin (TTM) N/A 60.28% N/A
Revenue per Share (TTM) $0 $157 Zota Health Care Limited
Earnings per Share (Diluted) $-0.18 $-23.94 Genesis IBRC India Ltd.
Beta (Stock Volatility) N/A 0.36 N/A

Genesis IBRC India Ltd. vs Zota Health Care Limited Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Genesis IBRC India Ltd.-4.96%0.00%-0.51%54.94%-14.33%37.72%
Zota Health Care Limited7.20%-2.47%-13.95%-6.24%-28.72%-24.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Genesis IBRC India Ltd.507.27%993.55%1,467.02%623.84%5,745.00%5,745.00%
Zota Health Care Limited12.58%278.03%548.16%1,137.98%1,137.98%1,137.98%

Performance & Financial Health Analysis: Genesis IBRC India Ltd. vs Zota Health Care Limited

MetricGENESISZOTA
Market Information
Market Cap i₹4.47B₹39.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i25056,411
90 Day Avg. Volume i31753,265
Last Close₹111.10₹1,225.60
52 Week Range₹19.25 - ₹181.30₹917.20 - ₹1,740.00
% from 52W High-38.72%-29.56%
All-Time High₹184.90 (Nov 11, 2025)₹1,740.00 (Nov 21, 2025)
% from All-Time High-39.91%-29.56%
Growth Metrics
Quarterly Revenue GrowthN/A0.98%
Quarterly Earnings GrowthN/A1.12%
Financial Health
Profit Margin (TTM) i0.02%-0.15%
Operating Margin (TTM) i-0.11%-0.16%
Return on Equity (TTM) i0.00%-0.25%
Debt to Equity (MRQ) i0.0056.90
Cash & Liquidity
Book Value per Share (MRQ)₹9.02₹103.04
Cash per Share (MRQ)₹5.26₹1.87
Operating Cash Flow (TTM) i₹0₹-1,007,999,000
Levered Free Cash Flow (TTM) i₹35.05M₹-563,984,000
Dividends
Last 12-Month Dividend Yield iN/A0.07%
Last 12-Month Dividend iN/A₹1.00

Valuation & Enterprise Metrics Analysis: Genesis IBRC India Ltd. vs Zota Health Care Limited

MetricGENESIS (Apr 24, 2026)ZOTA (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i57.89-62.53
Forward P/E iN/AN/A
PEG Ratio iN/A-0.59
Price to Sales (TTM) i1,399.838.34
Price to Book (MRQ) i9.9312.61
Market Capitalization
Market Capitalization i₹4.47B₹39.41B
Enterprise Value i₹944.70M₹45.66B
Enterprise Value Metrics
Enterprise to Revenue i326.109.66
Enterprise to EBITDA i26.95-126.59
Risk & Other Metrics
Beta iN/A0.36
Book Value per Share (MRQ) i₹9.02₹103.04

Financial Statements Comparison: Genesis IBRC India Ltd. vs Zota Health Care Limited

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGENESIS (2025)ZOTA (2025)
Revenue/Sales i02.93B
Cost of Goods Sold i01.44B
COGS % of Revenue i-49.0%
Gross Profit i01.49B
Gross Margin i-51.0%
Research & Development iN/AN/A
Operating Income (EBIT) i35.05M-480.90M
Operating Margin i--16.4%
EBITDA i35.05M-42.20M
EBITDA Margin i--1.4%
Pre-Tax Income i35.05M-576.44M
Pre-Tax Income % of Revenue i--19.7%
Income Tax i0-9.06M
Income Tax % of Revenue i--0.3%
Net Income (Profit) i35.05M-567.39M
Profit Margin i--19.4%

Balance Sheet & Liquidity Metrics

MetricGENESIS (2025)ZOTA (2025)
Cash & Equivalents i57,00021.32M
Total Current Assets i88.35M1.84B
Total Current Assets % of Revenue i-62.9%
Total Current Liabilities i3.03M1.01B
Total Current Liabilities % of Revenue i-34.3%
Long-Term Debt iN/A1.08B
Long-Term Debt % of Revenue i-36.7%
Total Shareholders Equity i85.33M2.27B
Retained Earnings i-83.06M-191.89M
Retained Earnings % of Revenue i--6.5%
Property, Plant & Equipment iN/A65.25M

Cash Flow Statement Comparison

MetricGENESIS (2025)ZOTA (2025)
Operating Cash Flow i0-1.01B
Operating Cash Flow % of Revenue i--34.4%
Capital Expenditures iN/A-459.67M
Free Cash Flow i-3,000-959.42M
FCF Margin i--32.7%
Debt Repayment iN/A-140.67M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricGENESISZOTA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i45.25M30.33M
Float Shares iN/A15.02M
% Held by Insiders i27.24%0.00%
% Held by Institutions i0.00%1.16%
% Held by Public i72.76%98.84%

Dividend Analysis & Yield Comparison: Genesis IBRC India Ltd. vs Zota Health Care Limited

MetricGENESISZOTA
Last 12-Month Dividend iN/A₹1.00
Last 12-Month Dividend Yield iN/A0.07%
3-Year Avg Annual Dividend iN/A₹1.00
3-Year Avg Dividend Yield iN/A0.16%
3-Year Total Dividends iN/A₹3.00
Ex-Dividend DateN/ASep 22, 2025